72631-80-2 Usage
Uses
Used in Biochemical and Pharmaceutical Research:
1H-Imidazol-4-ylmethylamine dihydrochloride is used as a histamine H2-receptor agonist for studying the biological effects and functions of histamine receptors. Its agonistic properties make it a valuable tool in understanding the role of histamine in various physiological processes.
Used in Drug Synthesis:
In the pharmaceutical industry, 1H-Imidazol-4-ylmethylamine dihydrochloride is used as a key intermediate in the synthesis of various drugs and pharmaceutical compounds. Its unique structure and functional groups contribute to the development of new therapeutic agents.
Used in Organic Chemistry:
1H-Imidazol-4-ylmethylamine dihydrochloride also finds applications in the field of organic chemistry, where it serves as a building block for the synthesis of more complex organic molecules. Its versatility in forming different chemical entities makes it a useful component in organic synthesis processes.
Check Digit Verification of cas no
The CAS Registry Mumber 72631-80-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,2,6,3 and 1 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 72631-80:
(7*7)+(6*2)+(5*6)+(4*3)+(3*1)+(2*8)+(1*0)=122
122 % 10 = 2
So 72631-80-2 is a valid CAS Registry Number.
72631-80-2Relevant academic research and scientific papers
MELANOCORTIN RECEPTOR MODULATORS, PROCESS FOR PREPARING THEM AND USE THEREOF IN HUMAN MEDICINE AND COSMETICS
-
Page/Page column 68, (2010/06/11)
The present invention relates to novel melanocortin receptor modulators corresponding to the general formula (I) to compositions containing them, to the process for preparing them and to their use in pharmaceutical or cosmetic compositions.
SUBSTITUTED BIARYLS, PROCESS FOR THEIR MANUFACTURE AND USE THEREOF AS MEDICAMENTS
-
Page/Page column 34, (2010/11/30)
The present invention relates to compounds of general formula (I) wherein A, B, L, R1, R2, R3a and R3b are defined as in the specification, the tautomers, the enantiomers, the diastereomers, the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, which have valuable properties.
TRANSITION-METAL BINDING SITE OF BLEOMYCIN. SIGNIFICANCE OF THE β-AMINOALANINAMIDE APPENDAGE IN REGULATING OXYGEN ACTIVATION
Sugiyama, Toru,Ohno, Masaji,Shibasaki, Masakatsu,Otsuka, Masami,Sugiura, Yukio,et al.
, p. 275 - 282 (2007/10/02)
A synthetic model study on the iron-binding site of bleomycin demonstrated that the dioxygen-activating properties of ligands largely depend on the characteristics of functional groups contained in the β-aminoalaninamide moiety.
